Famciclovir

Anti-TP53BP1 tumor protein p53 binding protein 1, 100ul UN 1

AntiHum Calgrnln A(S100A8)FITC(Clone CF-145,MseIgG2b)100ug

Antimicrobl Contact Layer,4x7(10x18cm)

General description Famciclovir is an antiviral drug, which is predominantly used in the treatment of herpes virus infection. It is an inactive prodrug, which on administration, undergoes rapid biotransformation to penciclovir.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Famciclovir is used in herpes virus infections and hepatitis B drug development research. It may be used as a reference compound.

Application Famciclovir is used in herpes virus infections and hepatitis B drug development research. It may be used as a reference compound.

InformationFamciclovir (BRL-42810) is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections.In vitroIn vivoCell Datacell lines：KYSE-520 cellsConcentrations：Incubation Time：Powder Purity:≥99%.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the